Johnson & Johnson JNJ-5207852 JNJ-7925476 JNJ-39393406 JNJ-42165279 JNJ-Q2 JNJ-54175446 JNJ-26990990 JNJ-55308942 Tebideutorexant JNJ-26489112 JNJ-18038683 JNJ-7777120 JNJ-20788560 ADX-71149 JNJ-28330835 JNJ-10397049 Quisinostat Mavatrep VUF-6002 JNJ-77242113 Seltorexant JNJ-3792165 Erdafitinib CR665 Apalutamide Esketamine Abiraterone acetate Peficitinib Yem language Canagliflozin Colony stimulating factor 1 receptor Janssen COVID-19 vaccine
Johnson & Johnson
JNJ-5207852
JNJ-7925476
JNJ-39393406
JNJ-42165279
JNJ-Q2
JNJ-54175446
JNJ-26990990
JNJ-55308942
Tebideutorexant
JNJ-26489112
JNJ-18038683
JNJ-7777120
JNJ-20788560
ADX-71149
JNJ-28330835
JNJ-10397049
Quisinostat
Mavatrep
VUF-6002
JNJ-77242113
Seltorexant
JNJ-3792165
Erdafitinib
CR665
Apalutamide
Esketamine
Abiraterone acetate
Peficitinib
Yem language
Canagliflozin
Colony stimulating factor 1 receptor
Janssen COVID-19 vaccine
JNJ-5207852
JNJ-7925476
JNJ-39393406
JNJ-42165279
JNJ-Q2
JNJ-54175446
JNJ-26990990
JNJ-55308942
Tebideutorexant
JNJ-26489112
JNJ-18038683
JNJ-7777120
JNJ-20788560
ADX-71149
JNJ-28330835
JNJ-10397049
Quisinostat
Mavatrep
VUF-6002
JNJ-77242113
Seltorexant
JNJ-3792165
Erdafitinib
CR665
Apalutamide
Esketamine
Abiraterone acetate
Peficitinib
Yem language
Canagliflozin
Colony stimulating factor 1 receptor
Janssen COVID-19 vaccine